leadf
logo-loader
LSE:MXC OTC:MGCLF FRA:H5O ASX:MXC

MGC Pharmaceuticals Ltd

Receive alerts
Market:
LSE
Market Cap:
£73.93 m
Price
3.10 GBX
Change
-2.36%
52 weeks high
9.30
52 weeks low
2.00

In brief

MGC Pharmaceuticals Ltd (ASX:MXC) is a Europe based biopharma company developing and supplying affordable standardised phytocannabinoid derived medicines.

The company has a number of research collaborations with world-renowned academic institutions.

MGC Pharma has a growing patient base in Australia, the UK, Brazil and Ireland and has a global distribution footprint via an extensive network of commercial partners.

Snapshot

MGC Pharma, which has three investigational medical products in three clinical trials, has reported a record quarter of sales and revenue.